HOMEVULNERABILITIESCVE-2016-8720
MEDIUM

CVE-2016-8720

CWE-74Published: April 13, 2017· Updated: Jun 17, 2026

4.3
CVSS v3.1

Official Description

An exploitable HTTP Header Injection vulnerability exists in the Web Application functionality of the Moxa AWK-3131A Wireless Access Point running firmware 1.1. A specially crafted HTTP request can inject a payload in the bkpath parameter which will be copied in to Location header of the HTTP response.

NVD Source

Technical Analysis

CVE-2016-8720 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation does not require any privileges, though user interaction (Required) is needed, which slightly reduces the risk of mass automated attacks.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionRequired
ScopeUnchanged
Impact
ConfidentialityNone
IntegrityLow
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N

Affected Vendors & Products

moxa2 product(s)
awk-3131a firmwareawk-3131a
Source: NVD CPE · 2 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (2)

http://www.talosintelligence.com/reports/TALOS-2016-0234/Exploit · Mitigation · Third Party Advisory
http://www.talosintelligence.com/reports/TALOS-2016-0234/Exploit · Mitigation · Third Party Advisory

Quick Facts

CVE IDCVE-2016-8720
CVSS Score4.3 / 10
SeverityMEDIUM
WeaknessCWE-74
CISA KEVNo
Affected1 vendor(s)
PublishedApr 13, 2017

Related CVEs (CWE-74)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2016-8720 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.